Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 323 results for "fda"

McD withdraws Coke Zero, rly canteens, malls under FDA lens

McD withdraws Coke Zero, rly canteens, malls under FDA lens

The food chain has now written to the FDA that they have stopped the sale of Coke Zero in their 60 outlets of which 40 are in Mumbai DNA, 6 hours ago
Maharashtra FDA bans Coke Zero at McDonald's Business Standard, 1 week ago

5,752 images for fda

Med India, 1 day ago
DNA, 6 hours ago
Med India, 1 week ago
Money Control, 4 days ago
Money Control, 1 week ago
Money Control, 1 week ago
Reuters, 1 week ago
Reuters, 1 week ago
Reuters, 2 weeks ago
DNA, 1 week ago

USFDA adds one more clause to import alert on Divi's Labs

BS ReporterHyderabad, 22 March: The US Food and Drug Administration(US FDA) has invoked one more clause with regard to the import alert issued to Unit-2 of Hyderabad-based Divis Laboratories Limited, this time charging the company with 'refusal for ...
 Business Standard4 days ago Divi's Labs barred from exports to US after FDA import alert on Vizag unit  Business Standard5 days ago Divi’s Labs plunges 17% on US FDA import alert on Vizag unit  Money Control6 days ago
India Infoline

Lupin receives FDA approval for Generic TOBI inhalation solution

Lupin has received final approval for its Tobramycin inhalation solution USP, 300 mg/ 5 ml from the United State Food Drug Administration to market a generic version of Novartis Pharmaceuticals Corporation�s TOBI 300 mg / 5 ml.
 Money Control3 days ago Lupin receives US FDA approval for tobramycin inhalation solution  Business Standard2 days ago Lupin gets FDA nod for generic version of Suprep  Money Control3 weeks ago Lupin receives FDA approval for tablets, oral solution  Prokerala3 weeks ago

Pfizer#39;s Hospira receives 11 FDA observations for Vizag unit

An inspection by the US Food and Drug Administration took place at the sterile injectables manufacturing unit between March 9 and 17.
 Money Control2 days ago FDA warns Pfizer over contaminated drugs at Kansas plant  Reuters3 weeks ago

Divis Laboratories: Updates on USFDA alert

The company has already initiated necessary measures to address the concerns raised by the US-FDA and is making all efforts to fully meet the compliance requirements.
 Money Control4 days ago Divis Lab: Update on USFDA inspection of Unit-II at Visakhapatnam  Money Control2 months ago
Money Control

Here’s what analysts feel about Dr Reddy’s Labs post US FDA observations

Typically, the US drug regulator conveys its concerns on manufacturing practices through Form 483. Companies that receive its observations must respond in writing with a corrective action plan and implement it quickly
 Money Control4 days ago Dr Reddy's gets 13 observations from USFDA for Duwada facility  Money Control2 weeks ago How Dr Reddy's plans to win the US market  Rediff.com1 week ago USFDA concludes inspection of Dr Reddy's Miryalaguda facility  Money Today1 month ago

Sun Pharma's Mohali plant out of US FDA's Import Alert list

Drug major Sun Pharmaceutical Industries Ltd on Tuesday said its production facility in Mohali in Punjab is out of US Food and Drug Administration's (US FDA) "Import Alert".In a statement, Sun Pharma said the US FDA on Monday informed that it will lift the ...
 Prokerala1 week ago US FDA lifts import alert imposed on Sun Pharma's Mohali facility  Business Standard1 week ago Alkem's Baddi manufacturing facility receives 3 observations from US FDA  Business Standard1 week ago Sun Pharma soars 6% on US FDA’s plan to lift import alert at Mohali  Money Control1 week ago

Divis Laboratories receives import alert 66-40 from USFDA

We wish to state that US-FDA has issued an Import Alert 66-40 on 20th March 2017 on the products manufactured at the company's Unit-II at Visakhapatnam, Andhra Pradesh.
 Money Control6 days ago Mfg norms, inspection issues led to USFDA alert on Divis Labs  Business Standard4 days ago

FDA Woes: Pharma Companies feel the US FDA heat

The US drug regulator off late, has been a cause of headaches for many domestic pharmaceutical companies. Today, shares of Divis Laboratories tanked 20 percent after an import alert was issued its on Vizag unit. The Dr Reddy#39;s Laboratories shares also hit ...
 Money Control5 days ago Alembic Pharma shares rise over 3 %; mcap rises by Rs 403 cr  Business Standard2 weeks ago Alembic Pharma's Baroda facility completes USFDA inspection  Business Standard2 weeks ago

FDA ने मैकडोनाल्ड्स में कोका कोला जीरो की बिक्री पर पूरे महाराष्ट्र में लगाई रोक

पुणे/मुंबई: फूड एंड ड्रग एडमिनिस्ट्रेशन ने मैकडोनाल्ड्स में कोका कोला जीरो की बिक्री पर पूरे ...
 Dainik Bhaskar6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less